Thema
610
18
Study Type: Interventional
13
Recruitment Status: Not yet recruiting
8
Phase: Phase 3
6
Recruitment Status: Completed
6
Study Type: Observational
5
Medical Condition: Clinical evaluation of Diallertest Patch Test used for diagnosis of delayed hypersensitivity to milk and wheat proteins. Allergen concentration is below TGA requirement for Registration. Product is registered in France and United Arab Emirates.Product Information Sheet is attached.; Clinical evaluation of Diallertest Patch Test used for diagnosis of delayed hypersensitivity to milk and wheat proteins. Allergen concentration is below TGA requirement for Registration. Product is registered in France and United Arab Emirates.Product Information Sheet is attached.;Skin - Other skin conditions;Diet and Nutrition - Other diet and nutrition disorders
2
Medical Condition: Immunogenic Study, in french children living in the region of Normandy, France, after vaccination for B:14,P1-7,16 bacterial strain. MedDRA version: 14.1Level: HLTClassification code 10027203Term: Meningeal bacterial infectionsSystem Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Immunogenic Study, in french children living in the region of Normandy, France, after vaccination for B:14:P1.7,16, to evaluate the longer-term persistence of antibodies against B:14P1.7,16. bacterial strain. MedDRA version: 14.1Level: HLTClassification code 10027203Term: Meningeal bacterial infectionsSystem Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Le lymphome non hodgkinien (LNH) de type folliculaire est une maladie incurable à un stade avancé. Il se caractérise par des rechutes fréquentes succédant à des rémissions de plus en plus rares et courtes, après des chimiothérapies successives. ZEVALIN®* (ibritumomab tiuxetan) est la première radio-immunothérapie (RIT) enregistrée en France. Elle est destinée aux patients adultes atteints d'un LNH folliculaire à cellules B CD20+, en rechute ou réfractaire au rituximab. MedDRA version: 9.1Level: LLTClassification code 10025310Term: Lymphoma
2
Medical Condition: Patients referred to our Physical Medicine Rehabilitation Department of a tertiary care center in Paris, France, for the management of Base-of-thumb osteoarthritis (BTOA) MedDRA version: 20.0Level: LLTClassification code 10062893Term: RhizarthrosisSystem Organ Class: 100000004859;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
2
Medical Condition: the aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
2
Phase: Phase 4
2
Recruitment Status: Authorised-recruitment may be ongoing or finished
2
Anemia, Iron-Deficiency
1
COVID-19
1
Carcinoma
1
Coronavirus Infections
1
Facies
1
Medical Condition: Air France Company's Employees Working in the Marseilles and Paris Airports (Flightline and Administrative Employees)
1
Medical Condition: Cervico-Facial Surgery ENT Academic Medical and Surgical Training in France, Cervico-Facial Surgery ENT Medical Residency (Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine and Provence-Alpes-Côte d'Azur Areas)
1
Medical Condition: Coronavirus Infections, COVID19 Outbreak in France
1
Medical Condition: Evaluate the Cost of a PIPAC Procedure and the Associated Hospital Stay in France
1
Medical Condition: Global Health of Asylum Seekers in France
1
Medical Condition: Iron Deficiency in Young Children Living in France
1
Mental Disorders
1
Psychotic Disorders
1
Recruitment Status: Recruiting
1
Recruitment Status: Terminated
1